Cerevel Therapeutics Holdings, Inc. (CERE)
NASDAQ: CERE · IEX Real-Time Price · USD
41.23
-0.12 (-0.29%)
Jul 2, 2024, 4:00 PM EDT - Market closed
CERE Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for CERE stock have an average target of 42.67, with a low estimate of 31 and a high estimate of 45. The average target predicts an increase of 3.49% from the current stock price of 41.23.
Analyst Consensus: Hold
* Price targets were last updated on Feb 16, 2024.
Analyst Ratings
The average analyst rating for CERE stock from 9 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 2 | 2 | 2 | 2 | 2 | 1 |
Hold | 10 | 10 | 10 | 10 | 10 | 8 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 12 | 12 | 12 | 12 | 12 | 9 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Mizuho | Mizuho | Hold Maintains $25 → $45 | Hold | Maintains | $25 → $45 | +9.14% | Feb 16, 2024 |
JP Morgan | JP Morgan | Hold Maintains $25 → $45 | Hold | Maintains | $25 → $45 | +9.14% | Dec 28, 2023 |
Jefferies | Jefferies | Strong Buy → Hold Downgrades $40 → $45 | Strong Buy → Hold | Downgrades | $40 → $45 | +9.14% | Dec 22, 2023 |
TD Cowen | TD Cowen | Buy → Hold Downgrades $45 | Buy → Hold | Downgrades | $45 | +9.14% | Dec 8, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $41 → $45 | Strong Buy → Hold | Downgrades | $41 → $45 | +9.14% | Dec 7, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.57
from -2.67
EPS Next Year
-2.86
from -2.57
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | 66.2M | 422.7M | 925.1M |
Avg | n/a | n/a | 42.1M | 291.7M | 767.2M |
Low | n/a | n/a | 19.1M | 92.3M | 352.5M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | 904.7% | 217.1% |
Avg | - | - | - | 593.3% | 163.0% |
Low | - | - | - | 119.4% | 20.8% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.85 | -2.67 | -3.10 | -1.70 | 0.06 |
Avg | -2.57 | -2.86 | -3.04 | -2.19 | -0.48 |
Low | -3.19 | -3.23 | -2.95 | -3.24 | -0.91 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.